skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases

Authors:
; ; ORCiD logo
Publication Date:
Sponsoring Org.:
USDOE Office of Nuclear Energy (NE), Fuel Cycle Technologies (NE-5)
OSTI Identifier:
1359011
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Drug Discovery Today
Additional Journal Information:
Journal Volume: 21; Journal Issue: 9; Related Information: CHORUS Timestamp: 2017-05-28 16:37:54; Journal ID: ISSN 1359-6446
Publisher:
Elsevier
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Rocha, Daniela N., Carvalho, Eva D., and Pêgo, Ana Paula. High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases. Country unknown/Code not available: N. p., 2016. Web. doi:10.1016/j.drudis.2016.05.005.
Rocha, Daniela N., Carvalho, Eva D., & Pêgo, Ana Paula. High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases. Country unknown/Code not available. doi:10.1016/j.drudis.2016.05.005.
Rocha, Daniela N., Carvalho, Eva D., and Pêgo, Ana Paula. 2016. "High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases". Country unknown/Code not available. doi:10.1016/j.drudis.2016.05.005.
@article{osti_1359011,
title = {High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases},
author = {Rocha, Daniela N. and Carvalho, Eva D. and Pêgo, Ana Paula},
abstractNote = {},
doi = {10.1016/j.drudis.2016.05.005},
journal = {Drug Discovery Today},
number = 9,
volume = 21,
place = {Country unknown/Code not available},
year = 2016,
month = 9
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1016/j.drudis.2016.05.005

Citation Metrics:
Cited by: 2works
Citation information provided by
Web of Science

Save / Share:
  • The present studies establish that there are specific, significant decreases in the neuronal calcium-binding protein (28-kDa calbindin-D) gene expression in aging and in neurodegenerative diseases. The specificity of the changes observed in calbindin mRNA levels was tested by reprobing blots with calmodulin, cyclophilin, and B-actin cDNAs. Gross brain regions of the aging rat exhibited specific, significant decreases in calbindin{center dot}mRNA and protein levels in the cerebellum, corpus striatum, and brain-stem region but not in the cerebral cortex or hippocampus. Discrete areas of the aging human brain exhibited significant decreases in calbindin protein and mRNA in the cerebellum, corpus striatum, andmore » nucleus basalis but not in the neocortex, hippocampus, amygdala, locus ceruleus, or nucleus raphe dorsalis. Comparison of diseased human brain tissue with age- and sex-matched controls yielded significant decreases calbindin protein and mRNA in the substantia nigra (Parkinson disease), in the corpus striatum (Huntington disease), in the nucleus basalis (Alzheimer disease), and in the hippocampus and nucleus raphe dorsalis (Parkinson, Huntington, and Alzheimer diseases) but not in the cerebellum, neocortex, amygdala, or locus ceruleus. These findings suggest that decreased calbindin gene expression may lead to a failure of calcium buffering or intraneuronal calcium homeostasis, which contributes to calcium-mediated cytotoxic events during aging and in the pathogenesis of neurodegenerative diseases.« less
  • Preliminary studies have shown associations between chronic pesticide exposure in occupational settings and neurological disorders. However, data on the effects of long-term non-occupational exposures are too sparse to allow any conclusions. This study examines the influence of environmental pesticide exposure on a number of neuropsychiatric conditions and discusses their underlying pathologic mechanisms. An ecological study was conducted using averaged prevalence rates of Alzheimer's disease, Parkinson's disease, multiple sclerosis, cerebral degeneration, polyneuropathies, affective psychosis and suicide attempts in selected Andalusian health districts categorized into areas of high and low environmental pesticide exposure based on the number of hectares devoted to intensivemore » agriculture and pesticide sales per capita. A total of 17,429 cases were collected from computerized hospital records (minimum dataset) between 1998 and 2005. Prevalence rates and the risk of having Alzheimer's disease, Parkinson's disease, multiple sclerosis and suicide were significantly higher in districts with greater pesticide use as compared to those with lower pesticide use. The multivariate analyses showed that the population living in areas with high pesticide use had an increased risk for Alzheimer's disease and suicide attempts and that males living in these areas had increased risks for polyneuropathies, affective disorders and suicide attempts. In conclusion, this study supports and extends previous findings and provides an indication that environmental exposure to pesticides may affect the human health by increasing the incidence of certain neurological disorders at the level of the general population. -- Highlights: Black-Right-Pointing-Pointer Environmental exposure to pesticides and neurodegenerative-psychiatric disorders. Black-Right-Pointing-Pointer Increased risk for Alzheimer's disease and suicide attempts in high exposure areas. Black-Right-Pointing-Pointer Males from areas with high pesticide exposure had a higher risk of polyneuropathy. Black-Right-Pointing-Pointer Males from high exposure areas had a higher risk of affective psychosis and suicide. Black-Right-Pointing-Pointer Nerve tissue degeneration due to oxidative damage may underlie the pathomechanism.« less